Cost-Effectiveness of a Fixed-Dose Combination Therapy of Lesinurad and Allopurinol for Second-Line Gout Therapy- A US Payer Perspective

May 1, 2018, 00:00
10.1016/j.jval.2018.04.1335
https://www.valueinhealthjournal.com/article/S1098-3015(18)31638-3/fulltext
Title : Cost-Effectiveness of a Fixed-Dose Combination Therapy of Lesinurad and Allopurinol for Second-Line Gout Therapy- A US Payer Perspective
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)31638-3&doi=10.1016/j.jval.2018.04.1335
First page :
Section Title :
Open access? : No
Section Order : 586
Categories :
Tags :
Regions :
ViH Article Tags :